Eliem Therapeutics, Inc

Q1 2026 13F Holders

Symbol
CLYM
CUSIP
28658R106
Type
Equity
Class
COM
Num filings
82
Total reported value, excl. options
$221 M
Manager Report Date Value ($000) Shares Option Type